Gabriella Miller Kids First Research Act 2.0
USA117th CongressS-1521| Senate
| Updated: 4/29/2021
Tim Kaine
Democratic Senator
Virginia
Cosponsors (12)
Bill Cassidy (Republican)Roger Marshall (Republican)Jerry Moran (Republican)Mark R. Warner (Democratic)Robert P. Casey (Democratic)Joe Manchin (Independent)Martin Heinrich (Democratic)Tina Smith (Democratic)Marco Rubio (Republican)Steve Daines (Republican)Lisa Murkowski (Republican)Shelley Moore Capito (Republican)
Health, Education, Labor, and Pensions Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Gabriella Miller Kids First Research Act 2.0 This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH). Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund. This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2365)
Latest Companion Bill Action
HR 117-623Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health
Banking and financial institutions regulationCancerChild healthCivil actions and liabilityDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment trust fundsHealth programs administration and fundingMedical researchNational Institutes of Health (NIH)Research administration and fundingSecuritiesSecurities and Exchange Commission (SEC)
Gabriella Miller Kids First Research Act 2.0
USA117th CongressS-1521| Senate
| Updated: 4/29/2021
Gabriella Miller Kids First Research Act 2.0 This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH). Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund. This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2365)
Latest Companion Bill Action
HR 117-623Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Tim Kaine
Democratic Senator
Virginia
Cosponsors (12)
Bill Cassidy (Republican)Roger Marshall (Republican)Jerry Moran (Republican)Mark R. Warner (Democratic)Robert P. Casey (Democratic)Joe Manchin (Independent)Martin Heinrich (Democratic)Tina Smith (Democratic)Marco Rubio (Republican)Steve Daines (Republican)Lisa Murkowski (Republican)Shelley Moore Capito (Republican)
Health, Education, Labor, and Pensions Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Banking and financial institutions regulationCancerChild healthCivil actions and liabilityDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment trust fundsHealth programs administration and fundingMedical researchNational Institutes of Health (NIH)Research administration and fundingSecuritiesSecurities and Exchange Commission (SEC)